| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.008 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |